RecruitingNot ApplicableNCT05977816

PROPEL-2: Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds

PROPEL-2 Prophylactic Negative Pressure Wound Therapy (NPWT) in Laparotomy Wounds: a Randomised Controlled Trial Comparing Negative Pressure Wound Therapy to Standard Wound Management in Patients Following Midline Laparotomy


Sponsor

Royal College of Surgeons, Ireland

Enrollment

2,000 participants

Start Date

Jul 14, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Post-operative wound issues in abdominal surgery have a significant impact on patient outcomes. This study is taking place to investigate if Negative Pressure Wound Therapy (NPWT) dressings reduces Surgical Site Infections, post surgical complications and improves scar appearance compared to standard dressings.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Aged 18 years or older
  • Patient requires visceral abdominal surgery via a midline laparotomy
  • Patients who can complete questionnaires

Exclusion Criteria1

  • • Patients who are unable to adhere to protocol requirements

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENegative Pressure Wound Therapy

Application of a negative wound pressure therapy dressing to the wound post laparotomy

OTHERStandard wound dressing

Application of a standard wound dressing to the wound post laparotomy


Locations(11)

Mayo University Hospital

Castlebar, Ireland

Beaumont Hospital

Dublin, Ireland

Mater Misericordiae University Hospital

Dublin, Ireland

St James's Hospital

Dublin, Ireland

Tallaght University Hospital

Dublin, Ireland

University Hospital Galway

Galway, Ireland

Letterkenny University Hospital

Letterkenny, Ireland

University Hospital Limerick

Limerick, Ireland

Sligo University Hospital

Sligo, Ireland

University hospital Kerry

Tralee, Ireland

University Hospital Waterford

Waterford, Ireland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05977816


Related Trials